25
Views
13
CrossRef citations to date
0
Altmetric
Research Article

In vitro migration of mononuclear cells towards synovial fluid and plasma from rheumatoid arthritis patients correlates to RANTES synovial fluid levels and to clinical pain parameters

Pages 216-221 | Published online: 12 Jul 2009

Reference

  • Luster AD. Chemokines-Chemotactic Cytokines That Med-iate Inflammation. N Engl J Med 1998;338:436–45.
  • Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993;268: 5834–9.
  • Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN. Chemokine expression in rheumatoid arthritis (RA). Evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 1995;101: 398–407.
  • Hosaka S, Akahoshi T, Wada C, Kondo H. Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol 1994;97:451–457.
  • Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 1998;89:44–53.
  • Gong JH, Uguccioni M, Dewald B, Baggiolini M, Clark Lewis I. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 1996;271:10521–7.
  • Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning., functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993;72: 415–25.
  • Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-lbeta, and MIP-lalpha. J Biol Chem 1996;271: 17161–6.
  • Plater Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997;57: 117–20.
  • Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K. Selective accumulation CCR5+ T-lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999;11:553–9.
  • Boiardi L, Macchioni P, Meliconi R, Pulsatelli L, Facchini A, Salvarani C. Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol 1999;17: 419–25.
  • Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727–35.
  • Furst DE. Considerations on measuring decreased inflamma-tory synovitis. ILAR Bull 1994;2:17–21.
  • van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34–40.
  • Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
  • Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393–406.
  • Jorgensen C, Couret I, Bologna C, Rossi M, Sany I. Radiolabelled lymphocyte migration in rheumatoid synovitis. Ann Rheum Dis 1995;54:39–44.
  • Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:123–9.
  • Fex E, Eberhardt K, Saxne T. Tissue derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: Relationship to development of joint destruction in hands and feet. Br J Rheumatol 1997;36:1161–5.
  • Wolfe F, Sharp JT. Radiographic outcome of recent onset rheumatoid arthritis, a 19 year study of radiographic progression. Arthritis Rheum 1998;41:1571–82.
  • van Leeuwen MA, van der Heijde DMFM, van Rijswijk MH, Houtman PM, van Riel PLCM, van de Putte LBA, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparaison of radiologic damage, physical disability, joint counts and acute phase reactants. J Rheumatol 1994;21:425–9.
  • Ingeman Nielsen M, Halskov O, Hansen TM, Halberg P, Stage P, Lorenzen I. Clinical synovitis and radiological lesions in rheumatoid arthritis. A prospective study of 25 patients during treatment with remission-inducing drugs. Scand J Rheumatol 1983;12: 237–40.
  • Mottonen T. Prediction of erosiveness and rate of develop-ment of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648–53.
  • Prevoo MLL, van Riel PLCM, van't Hof MA, van Rijswijk MH, van Leeuwen MA, Kuper HH, et al. Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol 1993;32:589–94.
  • Siveke JT, Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 1998;160:550–4.
  • Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.